“CARD invests in the research that advances our understanding of autism.”
CARD founder Dr. Doreen Granpeesheh is a pioneering researcher in the treatment of autism. After leading the seminal study at UCLA that demonstrated the effectiveness of applied behavior analysis (ABA) in treating the symptoms associated with autism, Dr. Granpeesheh continued her commitment to advance research on ABA at CARD, making CARD one of the nation’s largest non-governmental organizations investing in autism research. CARD research has contributed to the successful effort to mandate insurance funding of ABA throughout the United States and led to the seismic shift from home to center-based ABA when research demonstrated that children may double their rate of skill acquisition in a center environment.